🇺🇸 FDA
Pipeline program

Buprenorphine/naloxone Film Strip

RB-US-07-0001

Phase 2 small_molecule completed

Quick answer

Buprenorphine/naloxone Film Strip for Opioid-Related Disorders is a Phase 2 program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Indivior Pharmaceuticals
Indication
Opioid-Related Disorders
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials